As Access Declines,
Connected Engagement
Creates An Edge 

Veeva Pulse Field Trends Report

As the pharmaceutical industry continues to adapt to HCP preferences and hybrid commercial models, it’s critical to stay on top of evolving field and HCP engagement trends.

Each quarter, the Veeva Pulse Field Trends Report provides unique insights into global and regional engagement trends based on an analysis of 600 million HCP interactions across more than 80% of biopharmas worldwide.

Want to dive deeper?
Below are some of the top insights from previous Veeva Pulse Field Trends Reports. You can also access the full reports for comprehensive data and analysis.

HCP Access Declined From 60% to 45%

Access is back to pre-pandemic levels and HCPs remain highly selective – about half limit access to three or fewer biopharmas. But connected engagement across sales, marketing, and medical is giving HCPs what they need, when they need it.

3 Ways Biopharmas Are Using Field Insights To Better Engage HCPs

 Learn how Kyowa Kirin, Lundbeck, and Boehringer Ingelheim turn Veeva Pulse insights into action to empower field teams with content, engagement opportunities, and channels to build strong customer relationships that create lasting value for HCPs and patients.

Opening Up Two-Way Communication Doubles Digital Engagement

 As therapies become more precise and patient populations get smaller, HCPs want on-demand access to resources that help patients initiate treatment, from reimbursement support to site certification. Learn how your commercial team can create a service-focused engagement model that delivers with speed and value.

Achieve commercial excellence in sales, marketing, and medical

Help your field teams engage HCPs at the right time with the right omnichannel mix.